100 related articles for article (PubMed ID: 19910920)
1. Quality-of-care indicators for non-small cell lung cancer.
Tanvetyanon T
Cancer Control; 2009 Oct; 16(4):335-41. PubMed ID: 19910920
[TBL] [Abstract][Full Text] [Related]
2. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
[TBL] [Abstract][Full Text] [Related]
3. Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer.
Lennes IT; Lynch TJ
Clin Lung Cancer; 2009 Sep; 10(5):341-6. PubMed ID: 19808192
[TBL] [Abstract][Full Text] [Related]
4. Quality-of-care indicators for oesophageal cancer surgery: A review.
Courrech Staal EF; Wouters MW; Boot H; Tollenaar RA; van Sandick JW
Eur J Surg Oncol; 2010 Nov; 36(11):1035-43. PubMed ID: 20846818
[TBL] [Abstract][Full Text] [Related]
5. Treatment Patterns and Health Resource Utilization Among Patients Diagnosed With Early Stage Resected Non-Small Cell Lung Cancer at US Community Oncology Practices.
Buck PO; Saverno KR; Miller PJ; Arondekar B; Walker MS
Clin Lung Cancer; 2015 Nov; 16(6):486-95. PubMed ID: 25681298
[TBL] [Abstract][Full Text] [Related]
6. Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer.
Kassam F; Shepherd FA; Johnston M; Visbal A; Feld R; Darling G; Keshavjee S; Pierre A; Waddell T; Leighl NB
J Thorac Oncol; 2007 Jan; 2(1):39-43. PubMed ID: 17410008
[TBL] [Abstract][Full Text] [Related]
7. Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study.
Barni S; Maiello E; Di Maio M; Ardizzoni A; Cappuzzo F; Maranzano E; Novello S; Bennati C; Ori A; Rizzoli S; Crinò L;
Lung Cancer; 2015 Nov; 90(2):234-42. PubMed ID: 26314614
[TBL] [Abstract][Full Text] [Related]
8. Adopting integrated care pathways in non-small-cell lung cancer: from theory to practice.
Fasola G; Rizzato S; Merlo V; Aita M; Ceschia T; Giacomuzzi F; Lugatti E; Meduri S; Morelli A; Rocco M; Tozzi V
J Thorac Oncol; 2012 Aug; 7(8):1283-90. PubMed ID: 22653077
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of bevacizumab for unresectable non-small-cell lung cancer: a meta-analysis.
Yang K; Wang YJ; Chen XR; Chen HN
Clin Drug Investig; 2010; 30(4):229-41. PubMed ID: 20225906
[TBL] [Abstract][Full Text] [Related]
10. Peri- and postoperative management of stage I-III Non Small Cell Lung Cancer: Which quality of care indicators are evidence-based?
Numan RC; Berge MT; Burgers JA; Klomp HM; van Sandick JW; Baas P; Wouters MW
Lung Cancer; 2016 Nov; 101():129-136. PubMed ID: 27794401
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
12. A cross-country review of data collected on non-small cell lung cancer (NSCLC) patients in cancer registries, databases, retrospective and non-randomized prospective studies.
De Geer A; Eriksson J; Finnern HW
J Med Econ; 2013; 16(1):134-49. PubMed ID: 22702446
[TBL] [Abstract][Full Text] [Related]
13. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
14. A comparison of quality and cost indicators by surgical specialty for lobectomy of the lung.
Freeman RK; Dilts JR; Ascioti AJ; Giannini T; Mahidhara RJ
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):68-73; discussion 73-4. PubMed ID: 23058669
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
Jiang J; Liang X; Zhou X; Huang R; Chu Z
Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelines.
de Marinis F; Rossi A; Di Maio M; Ricciardi S; Gridelli C;
Lung Cancer; 2011 Jul; 73(1):1-10. PubMed ID: 21440325
[TBL] [Abstract][Full Text] [Related]
17. Quality of care of patients with non-small-cell lung cancer: a report of a performance improvement initiative.
Hirsch FR; Jotte RM; Berry CA; Mencia WA; Stowell SA; Gardner AJ
Cancer Control; 2014 Jan; 21(1):90-7. PubMed ID: 24357747
[TBL] [Abstract][Full Text] [Related]
18. The role of adjuvant chemotherapy for non-small cell lung cancer.
Gurubhagavatula S; Lynch TJ
Semin Respir Crit Care Med; 2005 Jun; 26(3):298-303. PubMed ID: 16052431
[TBL] [Abstract][Full Text] [Related]
19. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
